Efficacy of clopidogrel and ticagrelor under NT-proBNP in hospitalized ST-elevation acute coronary syndrome patients on percutaneous coronary intervention: CCC-ACS Project Analysis

Risk stratification with specific biomarkers is proposed for tailored P2Y12 inhibitor therapy in patients with STEMI.

Source: International Journal of Cardiology - April 6, 2020 Category: Cardiology Authors: Xin Zhao, Guannan Ai, Miaohan Qiu, Xiaozeng Wang, Lei Zhang, Xiaoxu Yang, Yifei Liu, Pei Xu, Jiyuan Zhang, Chonghuai Gu, Mengge Zhou, Yongchen Hao, Dong Zhao, Yaling Han, On behalf of CCC investigators Source Type: research